BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26160439)

  • 1. The potential role of the sodium iodide symporter gene polymorphism in the development of differentiated thyroid cancer.
    Al-Rasheed MM; Alzahrani AS; Macadam A; Overall A; Gard P; Dzimiri N
    Gene; 2015 Nov; 572(2):163-8. PubMed ID: 26160439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
    Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
    Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
    Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the role of GATA2 gene polymorphism in coronary artery disease risk traits.
    Muiya NP; Wakil S; Al-Najai M; Tahir AI; Baz B; Andres E; Al-Boudari O; Al-Tassan N; Al-Shahid M; Meyer BF; Dzimiri N
    Gene; 2014 Jul; 544(2):152-8. PubMed ID: 24786211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel loss-of-function deletion in sodium/iodide symporter gene in follicular thyroid adenoma.
    Liang JA; Chen CP; Huang SJ; Ho TY; Hsiang CY; Ding HJ; Wu SL
    Cancer Lett; 2005 Dec; 230(1):65-71. PubMed ID: 16253762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Ren Y; Lence-Anta JJ; Pereda CM; Chappe M; Velasco M; Infante I; Bustillo M; Turcios S; Leufroy A; Guérin T; Noël L; Lesueur F; Maillard S; Cléro E; Xhaard C; Allodji RS; Rubino C; Rodriguez R; Ortiz RM; de Vathaire F
    Thyroid; 2016 Dec; 26(12):1752-1760. PubMed ID: 27610545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
    Sturgis EM; Zhao C; Zheng R; Wei Q
    Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
    Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.
    Ho T; Li G; Zhao C; Wei Q; Sturgis EM
    Laryngoscope; 2005 Jun; 115(6):1035-41. PubMed ID: 15933516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk.
    Akdi A; Pérez G; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
    Thyroid; 2011 May; 21(5):519-25. PubMed ID: 21476894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WDR3 gene haplotype is associated with thyroid cancer risk in a Spanish population.
    Akdi A; Giménez EM; García-Quispes W; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
    Thyroid; 2010 Jul; 20(7):803-9. PubMed ID: 20578902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
    Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma.
    Chiang FY; Wu CW; Hsiao PJ; Kuo WR; Lee KW; Lin JC; Liao YC; Juo SH
    Clin Cancer Res; 2008 Sep; 14(18):5919-24. PubMed ID: 18779313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.